Criteria Caixa’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-127,684
Closed -$9.83M 17
2024
Q2
$9.83M Sell
127,684
-237,246
-65% -$17.4M 1.31% 17
2024
Q1
$25M Sell
364,930
-68,134
-16% -$4.38M 2.67% 14
2023
Q4
$25M Sell
433,064
-2,000
-0.5% -$107K 2.8% 16
2023
Q3
$23M Sell
435,064
-25,512
-6% -$1.34M 2.84% 14
2023
Q2
$24.9M Sell
460,576
-160,071
-26% -$8.36M 2.97% 15
2023
Q1
$31.1M Hold
620,647
3.68% 11
2022
Q4
$28.7M Hold
620,647
3.63% 10
2022
Q3
$24M Buy
620,647
+58,700
+10% +$2.35M 3.43% 10
2022
Q2
$20.9M Buy
561,947
+15,273
+3% +$622K 2.77% 14
2022
Q1
$24.2M Buy
546,674
+38,276
+8% +$1.66M 2.78% 14
2021
Q4
$21.6M Buy
508,398
+87,202
+21% +$3.66M 2.67% 17
2021
Q3
$18.3M Hold
421,196
2.52% 17
2021
Q2
$18M Buy
421,196
+31,000
+8% +$1.3M 2.59% 16
2021
Q1
$15.1M Buy
390,196
+339,496
+670% +$12.8M 2.4% 16
2020
Q4
$1.82M Buy
+50,700
New +$1.83M 0.34% 25

Other funds holding BSX

Criteria Caixa's BSX Position: Q3 2024 in Review

Criteria Caixa sold out of Boston Scientific (BSX) in Q3 2024, closing a stake of 127,684 shares — an estimated $9.83M sold.

Criteria Caixa first reported a position in BSX in Q4 2020 and held it in 15 quarters. The position peaked at $31.1M in Q1 2023. 1,399 funds tracked by Wall St. Rank hold BSX as of Q3 2024.

  • Criteria Caixa reported no remaining Boston Scientific position as of Q3 2024 after selling out during the quarter.
  • Criteria Caixa sold 127,684 Boston Scientific shares in Q3 2024, an estimated $9.83M.
  • Criteria Caixa first reported a position in Boston Scientific in Q4 2020 and held it in 15 quarters.
  • Criteria Caixa's Boston Scientific position peaked at $31.1M in Q1 2023.
  • 1,399 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2024.

Based on Criteria Caixa's 13F filing for Q3 2024, filed 18 Mar 2025.